Listen to Dr Jean Bourbeau’s discussion of the elevated risks faced by people with respiratory illnesses in the face of a COVID-19 diagnosis. Dr Bourbeau is involved in the CanCOLD study which aims to improve early diagnosis and treatment of people with COPD. He is a member of the RESP program and an associate member of the Meakins-Christie Laboratories.
Listen here:
Le COVID-19 et les risques pour les personnes aux prises avec des problèmes respiratoires : entrevue avec Dr Jean Bourbeau, pneumologue au CUSM – 98.5 FM